Diabetes

According to the American Diabetes Association…

More than 30.3 million Americans, or 9.4% of the population, have diabetes.

According to the American Diabetes Association…

About 193,000 Americans under age 20 are estimated to have diagnosed diabetes, approximately 0.24% of that population.

According to the American Diabetes Association…

The percentage of Americans age 65 and older remains high, at 25.2%, or 12 million seniors (diagnosed and undiagnosed).

According to the American Diabetes Association…

1.5 million Americans are diagnosed with diabetes every year.

According to the American Diabetes Association…

Diabetes remains the 7th leading cause of death in the United States.

According to the American Diabetes Association…

$327 billion: Total costs of diagnosed diabetes in the United States (2017).

Diabetes

We know what it’s like to discover and develop therapies and diagnostics in diabetes and the specific challenges to their clinical development.

Diabetes Knowledge and Experience

Diabetes and related conditions are a long-term speciality of our senior team. Our track record in diabetes includes:

  • evaluation of research programs
  • discovery and development of molecules
  • discovery and development of devices

Our knowledge of early stages of clinical research and hands-on experience of registration trials, has made us a key partner in the field of diabetes. Our senior team set up one of the world’s largest clinical trials in diabetic neuropathy, retinopathy, and nephropathy. Our development programs have included:

  • insulin sensitization
  • hepatoselective insulin
  • diabetic hypertriglyceridemia
  • diabetic vascular disease
  • diabetic gustatory sweating
  • other research and development programs

We have helped client companies sharpen endpoints for their diagnostic devices and identify the best analyte or readout for their platform. Our team has worked at an executive level in companies which are global leaders in diabetes. The executive team found and ran drug discovery and development companies in the field of diabetes and related conditions for over 15 years. Our drug discovery experience includes:

  • characterizing new targets
  • Initiating assay development
  • performing proof of principle studies
  • synthesizing novel chemical structures
  • conducting preclinical pharmacology, pharmacokinetic/metabolism, toxicology, and pharmacodynamic studies

Our unique understanding of the key factors for success in both ground-breaking discovery projects, diagnostics and devices, clinical trials, and later-stage post marketing trials ensures success in any program.

In short, we know what it’s like to discover and develop therapies and diagnostics in diabetes and the specific challenges to their clinical development.

Diabetes Network

Over the last 30 years we have built close relationship with the majority of the world’s academic and clinical leaders in the field. Our academic collaborators work closely with our regional offices, giving us a deep understanding of current international priorities and local issues.

World Map

Partnering with You

Whether you are in early stage development and need advice and guidance to embark on your pre-clinical development, or a well-established organization designing later stage clinical trials, our professionals have the experience and network to provide both insight and execution. Our diabetes team works with you to deliver your projects on time and on budget.

 

 

Statistics provided in the banner of this Diabetes page is provided by the American Diabetes Association.